TABLE 10.
ADVERSE EFFECTS | PRESENT STUDY* (N=20) | NOFAL ET AL*26 (N=70) | DHOPE ET AL*27 (N=20) |
---|---|---|---|
Swelling at injection site | 1 (5%) | N/A | 4 (20%) |
Itching | 2 (10%) | N/A | N/A |
Swelling with pain | 1 (5%) | N/A | N/A |
Pain during injection | N/A | 60 (85.7%) | 17 (85%) |
Flu-like symptoms | N/A | 6 (8.6%) | 2 (10%) |
Erythema | N/A | N/A | 5 (25%) |
Acute urticaria exacerbation | 1 (5%) | N/A | N/A |
MMR: measles, mumps, and rubella; N/A: not applicable